{
    "nctId": "NCT01314898",
    "officialTitle": "A Phase 1, Double-Blind (Sponsor-Open), Placebo- And Active-Controlled, Single Dose, Crossover Study To Assess Antimineralocorticoid Activity Of Oral Pf-03882845 In Healthy Subjects.",
    "inclusionCriteria": "* Male and/or female healthy volunteers, age 18 to 55 years. Females must be of non-childbearing potential.\n* Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight \\>50 kg (110 lbs).\n* Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, diet restrictions and other trial procedures.\n* Must have minimum age of 18 Years\n* Must have maximum age of 55 Years",
    "exclusionCriteria": "* Subjects with a supine BP \\>140 mm Hg systolic or \\>90 mm Hg diastolic or \\<100 mm Hg systolic or \\<60 mm Hg diastolic based on the average of the triplicate\n* Serum potassium \\>=5.1 mmol/L or \\<3.5 mmol/L at screening, confirmed by a single repeat if deemed necessary.\n* Estimated GFR \\<60 mL/min/1.73 m2 using the Cockcroft-Gault formula measurement of the individual parameters following at least 5 minutes of rest at Screening."
}